Oracle [ORCL] vs Synopsys [SNPS] Detailed Stock Comparison
Oracle
NYSE
Loading...
Synopsys
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Oracle wins in 10 metrics, Synopsys wins in 9 metrics, with 0 ties. Oracle appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Oracle | Synopsys | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 54.12 | 69.96 | Oracle |
| Price-to-Book Ratio | 32.31 | 9.49 | Synopsys |
| Debt-to-Equity Ratio | 519.59 | 108.34 | Synopsys |
| PEG Ratio | 32.88 | 4.18 | Synopsys |
| EV/EBITDA | 32.34 | 61.54 | Oracle |
| Profit Margin (TTM) | 21.68% | 34.77% | Synopsys |
| Operating Margin (TTM) | 32.48% | 23.46% | Oracle |
| EBITDA Margin (TTM) | 32.48% | 23.46% | Oracle |
| Return on Equity | 82.38% | 15.55% | Oracle |
| Return on Assets (TTM) | 7.26% | 4.67% | Oracle |
| Free Cash Flow (TTM) | $-394.00M | $1.28B | Synopsys |
| Dividend Yield | 0.81% | N/A | N/A |
| 1-Year Return | 66.61% | 14.90% | Oracle |
| Price-to-Sales Ratio (TTM) | 11.52 | 18.04 | Oracle |
| Enterprise Value | $759.52B | $90.59B | Oracle |
| EV/Revenue Ratio | 13.23 | 14.56 | Oracle |
| Gross Profit Margin (TTM) | 70.19% | 80.16% | Synopsys |
| Revenue per Share (TTM) | $21 | $40 | Synopsys |
| Earnings per Share (Diluted) | $4.35 | $8.67 | Synopsys |
| Beta (Stock Volatility) | 1.43 | 1.15 | Synopsys |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Oracle vs Synopsys Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Oracle | -0.41% | -5.48% | -3.96% | 45.40% | 39.68% | 41.79% |
| Synopsys | -1.57% | -4.53% | -0.76% | 16.65% | 30.36% | 23.67% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Oracle | 66.61% | 215.22% | 322.41% | 549.05% | 927.09% | 1,658.10% |
| Synopsys | 14.90% | 80.60% | 185.67% | 1,181.12% | 2,420.05% | 3,080.61% |
Performance & Financial Health Analysis: Oracle vs Synopsys
| Metric | ORCL | SNPS |
|---|---|---|
| Market Information | ||
| Market Cap | $661.23B | $112.23B |
| Market Cap Category | Mega cap | Large cap |
| 10 Day Avg. Volume | 10,302,137 | 1,056,140 |
| 90 Day Avg. Volume | 10,197,732 | 1,979,477 |
| Last Close | $235.41 | $597.00 |
| 52 Week Range | $118.86 - $260.87 | $365.74 - $651.73 |
| % from 52W High | -9.76% | -8.40% |
| All-Time High | $260.87 (Jul 31, 2025) | $651.72 (Jul 30, 2025) |
| % from All-Time High | -9.76% | -8.40% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.11% | 0.10% |
| Quarterly Earnings Growth | 0.09% | 0.18% |
| Financial Health | ||
| Profit Margin (TTM) | 0.22% | 0.35% |
| Operating Margin (TTM) | 0.32% | 0.23% |
| Return on Equity (TTM) | 0.82% | 0.16% |
| Debt to Equity (MRQ) | 519.59 | 108.34 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $7.29 | $63.91 |
| Cash per Share (MRQ) | $3.99 | $91.93 |
| Operating Cash Flow (TTM) | $20.82B | $1.23B |
| Levered Free Cash Flow (TTM) | $678.00M | $1.94B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.81% | N/A |
| Last 12-Month Dividend | $1.70 | N/A |
Valuation & Enterprise Metrics Analysis: Oracle vs Synopsys
| Metric | ORCL | SNPS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 54.12 | 69.96 |
| Forward P/E | 32.88 | 40.79 |
| PEG Ratio | 32.88 | 4.18 |
| Price to Sales (TTM) | 11.52 | 18.04 |
| Price to Book (MRQ) | 32.31 | 9.49 |
| Market Capitalization | ||
| Market Capitalization | $661.23B | $112.23B |
| Enterprise Value | $759.52B | $90.59B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 13.23 | 14.56 |
| Enterprise to EBITDA | 32.34 | 61.54 |
| Risk & Other Metrics | ||
| Beta | 1.43 | 1.15 |
| Book Value per Share (MRQ) | $7.29 | $63.91 |
Financial Statements Comparison: Oracle vs Synopsys
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ORCL | SNPS |
|---|---|---|
| Revenue/Sales | $15.90B | $1.60B |
| Cost of Goods Sold | $4.74B | $318.35M |
| Gross Profit | $11.16B | $1.29B |
| Research & Development | $2.65B | $553.98M |
| Operating Income (EBIT) | $5.19B | $376.43M |
| EBITDA | $7.00B | $490.66M |
| Pre-Tax Income | $4.15B | $396.19M |
| Income Tax | $725.00M | $47.18M |
| Net Income (Profit) | $3.43B | $345.11M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ORCL | SNPS |
|---|---|---|
| Cash & Equivalents | $10.79B | $14.12B |
| Total Current Assets | $24.58B | $16.88B |
| Total Current Liabilities | $32.64B | $2.41B |
| Long-Term Debt | $96.83B | $10.62B |
| Total Shareholders Equity | $20.97B | $9.92B |
| Retained Earnings | $-15.48B | $9.62B |
| Property, Plant & Equipment | $0 | $1.16B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ORCL | SNPS |
|---|---|---|
| Operating Cash Flow | $5.93B | $275.78M |
| Capital Expenditures | N/A | $18.69M |
| Free Cash Flow | $-2.92B | $219.78M |
| Debt Repayment | $-6.07B | $0 |
| Common Stock Repurchase | $-150.00M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ORCL | SNPS |
|---|---|---|
| Shares Short | 20.69M | 3.98M |
| Short Ratio | 1.58 | 1.67 |
| Short % of Float | 0.01% | 0.02% |
| Average Daily Volume (10 Day) | 10,302,137 | 1,056,140 |
| Average Daily Volume (90 Day) | 10,197,732 | 1,979,477 |
| Shares Outstanding | 2.81B | 154.11M |
| Float Shares | 1.64B | 154.27M |
| % Held by Insiders | 0.42% | 0.00% |
| % Held by Institutions | 0.45% | 0.81% |
Dividend Analysis & Yield Comparison: Oracle vs Synopsys
| Metric | ORCL | SNPS |
|---|---|---|
| Last 12-Month Dividend | $1.70 | N/A |
| Last 12-Month Dividend Yield | 0.81% | N/A |
| 3-Year Avg Annual Dividend | $1.55 | N/A |
| 3-Year Avg Dividend Yield | 0.36% | N/A |
| 3-Year Total Dividends | $4.66 | N/A |
| Ex-Dividend Date | Apr 10, 2025 | N/A |